The Use of Ropivacaine in Therapeutic Treatment of Oral Aphthosis

Giulio Gasparini, Gianmarco Saponaro, Daniela Gasparini, Enrico Foresta, Camillo Azzuni, Alessia Adduci, Roberto Boniello, Alessandro Moro, Paolo De Angelis, Francesco Di Nardo, Giuseppe Damato, Piero Doneddu, Mattia Todaro, Umberto Garagiola, Sando Pelo

Research output: Contribution to journalArticle

Abstract

The use of anaesthetic drugs in the treatment of oral aphthosis is one of the pharmaceutical possibilities that a doctor can use for the most painful forms. Normally, Lidocaine or Diclofenac is used to treat this disease, but they can be used for a very limited time and so they are of little practical use. In this study, the authors have used Ropivacaine whose pharmaceutical kinetics allows the analgesic effect to be active for 60 to 90 minutes. In our research, we compared 8 groups of patients who have been given 3 principal pharmaceutical products: one group was given an anaesthetic drug, one had a topical medication administered which is often used for the treatment of aphthous lesions, and the last group was given a multivitamin. These pharmaceutical products were used alone and in various possible combinations in the 8 groups. The results of this study are very interesting and show that in all the groups that used anaesthetics there was more satisfaction on the patients' part because their pain level became more manageable right after the first application of the drug and the patients could carry on with their normal lives.

Original languageEnglish
Article number1868254
JournalBioMed Research International
Volume2018
DOIs
Publication statusPublished - Jan 1 2018

Fingerprint

Anesthetics
Pharmaceutical Preparations
Therapeutics
Diclofenac
Lidocaine
Patient Satisfaction
Analgesics
ropivacaine
Pain
Kinetics
Research

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)
  • Immunology and Microbiology(all)

Cite this

Gasparini, G., Saponaro, G., Gasparini, D., Foresta, E., Azzuni, C., Adduci, A., ... Pelo, S. (2018). The Use of Ropivacaine in Therapeutic Treatment of Oral Aphthosis. BioMed Research International, 2018, [1868254]. https://doi.org/10.1155/2018/1868254

The Use of Ropivacaine in Therapeutic Treatment of Oral Aphthosis. / Gasparini, Giulio; Saponaro, Gianmarco; Gasparini, Daniela; Foresta, Enrico; Azzuni, Camillo; Adduci, Alessia; Boniello, Roberto; Moro, Alessandro; De Angelis, Paolo; Di Nardo, Francesco; Damato, Giuseppe; Doneddu, Piero; Todaro, Mattia; Garagiola, Umberto; Pelo, Sando.

In: BioMed Research International, Vol. 2018, 1868254, 01.01.2018.

Research output: Contribution to journalArticle

Gasparini, G, Saponaro, G, Gasparini, D, Foresta, E, Azzuni, C, Adduci, A, Boniello, R, Moro, A, De Angelis, P, Di Nardo, F, Damato, G, Doneddu, P, Todaro, M, Garagiola, U & Pelo, S 2018, 'The Use of Ropivacaine in Therapeutic Treatment of Oral Aphthosis', BioMed Research International, vol. 2018, 1868254. https://doi.org/10.1155/2018/1868254
Gasparini G, Saponaro G, Gasparini D, Foresta E, Azzuni C, Adduci A et al. The Use of Ropivacaine in Therapeutic Treatment of Oral Aphthosis. BioMed Research International. 2018 Jan 1;2018. 1868254. https://doi.org/10.1155/2018/1868254
Gasparini, Giulio ; Saponaro, Gianmarco ; Gasparini, Daniela ; Foresta, Enrico ; Azzuni, Camillo ; Adduci, Alessia ; Boniello, Roberto ; Moro, Alessandro ; De Angelis, Paolo ; Di Nardo, Francesco ; Damato, Giuseppe ; Doneddu, Piero ; Todaro, Mattia ; Garagiola, Umberto ; Pelo, Sando. / The Use of Ropivacaine in Therapeutic Treatment of Oral Aphthosis. In: BioMed Research International. 2018 ; Vol. 2018.
@article{3e2ee807eafc498c9870cdcb8e915fb6,
title = "The Use of Ropivacaine in Therapeutic Treatment of Oral Aphthosis",
abstract = "The use of anaesthetic drugs in the treatment of oral aphthosis is one of the pharmaceutical possibilities that a doctor can use for the most painful forms. Normally, Lidocaine or Diclofenac is used to treat this disease, but they can be used for a very limited time and so they are of little practical use. In this study, the authors have used Ropivacaine whose pharmaceutical kinetics allows the analgesic effect to be active for 60 to 90 minutes. In our research, we compared 8 groups of patients who have been given 3 principal pharmaceutical products: one group was given an anaesthetic drug, one had a topical medication administered which is often used for the treatment of aphthous lesions, and the last group was given a multivitamin. These pharmaceutical products were used alone and in various possible combinations in the 8 groups. The results of this study are very interesting and show that in all the groups that used anaesthetics there was more satisfaction on the patients' part because their pain level became more manageable right after the first application of the drug and the patients could carry on with their normal lives.",
author = "Giulio Gasparini and Gianmarco Saponaro and Daniela Gasparini and Enrico Foresta and Camillo Azzuni and Alessia Adduci and Roberto Boniello and Alessandro Moro and {De Angelis}, Paolo and {Di Nardo}, Francesco and Giuseppe Damato and Piero Doneddu and Mattia Todaro and Umberto Garagiola and Sando Pelo",
year = "2018",
month = "1",
day = "1",
doi = "10.1155/2018/1868254",
language = "English",
volume = "2018",
journal = "BioMed Research International",
issn = "2314-6133",
publisher = "Hindawi Publishing Corporation",

}

TY - JOUR

T1 - The Use of Ropivacaine in Therapeutic Treatment of Oral Aphthosis

AU - Gasparini, Giulio

AU - Saponaro, Gianmarco

AU - Gasparini, Daniela

AU - Foresta, Enrico

AU - Azzuni, Camillo

AU - Adduci, Alessia

AU - Boniello, Roberto

AU - Moro, Alessandro

AU - De Angelis, Paolo

AU - Di Nardo, Francesco

AU - Damato, Giuseppe

AU - Doneddu, Piero

AU - Todaro, Mattia

AU - Garagiola, Umberto

AU - Pelo, Sando

PY - 2018/1/1

Y1 - 2018/1/1

N2 - The use of anaesthetic drugs in the treatment of oral aphthosis is one of the pharmaceutical possibilities that a doctor can use for the most painful forms. Normally, Lidocaine or Diclofenac is used to treat this disease, but they can be used for a very limited time and so they are of little practical use. In this study, the authors have used Ropivacaine whose pharmaceutical kinetics allows the analgesic effect to be active for 60 to 90 minutes. In our research, we compared 8 groups of patients who have been given 3 principal pharmaceutical products: one group was given an anaesthetic drug, one had a topical medication administered which is often used for the treatment of aphthous lesions, and the last group was given a multivitamin. These pharmaceutical products were used alone and in various possible combinations in the 8 groups. The results of this study are very interesting and show that in all the groups that used anaesthetics there was more satisfaction on the patients' part because their pain level became more manageable right after the first application of the drug and the patients could carry on with their normal lives.

AB - The use of anaesthetic drugs in the treatment of oral aphthosis is one of the pharmaceutical possibilities that a doctor can use for the most painful forms. Normally, Lidocaine or Diclofenac is used to treat this disease, but they can be used for a very limited time and so they are of little practical use. In this study, the authors have used Ropivacaine whose pharmaceutical kinetics allows the analgesic effect to be active for 60 to 90 minutes. In our research, we compared 8 groups of patients who have been given 3 principal pharmaceutical products: one group was given an anaesthetic drug, one had a topical medication administered which is often used for the treatment of aphthous lesions, and the last group was given a multivitamin. These pharmaceutical products were used alone and in various possible combinations in the 8 groups. The results of this study are very interesting and show that in all the groups that used anaesthetics there was more satisfaction on the patients' part because their pain level became more manageable right after the first application of the drug and the patients could carry on with their normal lives.

UR - http://www.scopus.com/inward/record.url?scp=85045033305&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85045033305&partnerID=8YFLogxK

U2 - 10.1155/2018/1868254

DO - 10.1155/2018/1868254

M3 - Article

C2 - 29713640

AN - SCOPUS:85045033305

VL - 2018

JO - BioMed Research International

JF - BioMed Research International

SN - 2314-6133

M1 - 1868254

ER -